Answers are grounded in this paper and cite their sources.
Introduction: Inflammatory bowel diseases are the result of an interaction between environmental, genetic and immunological factors, which result in a persistent inflammatory process in the intestines. The relationship between the intestinal microbiota and its influence and possible changes in IBD is not completely clear, however it is believed that the existence of a local inflammatory process generates changes, i.e. intestinal dysbiosis, often associated with the development of symptoms. The treatment of IBD depends on the signs and symptoms presented by the patient and may include aminosalicylates, corticosteroids, immunosuppressants and anti-TNF biological therapy. Objective: To address and synthesize information on the use of bacteriophages in the treatment of inflammatory bowel disease. Methodology: This is a literature review, the bases of which were taken from the SciELO and PubMed databases. The research period was from August 2023, meeting the inclusion criteria of articles from 2003 to 2023, in Portuguese and English, online texts and in full texts. Literature review: Currently, the search for the use of Bacteriophages, which are viruses that parasitize specific bacteria and are capable of invading the membrane and participating in the regulation of activity and can act by decreasing the response to inflammation. Thus, the search is for their use to control and regulate the process of intestinal dysbiosis and reduce the symptoms of IBD, since it controls multidrug-resistant bacteria. As well as being a controlled and monitored treatment, which has already proven to be an efficient treatment. Since the use of bacteriophages as antimicrobial agents has been increasing, it is necessary to understand their fields of application, since they are currently used from water and food safety to animal health. At the same time, the sensory and nutritional properties of food must always be preserved, and therefore, bacteriophages play an important role, as they are an alternative measure for this pathology. Conclusion: Thus, it is understood that IBD has increased in incidence, due to several factors existing in today's society, as well as new pharmacological measures being necessary, therefore, treatments should be encouraged and monitored, such as the use of bacteriophages, which has shown positive results.
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: